Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 0 | 0 | 0 | 0 | 5,207 |
| Gross Profit | N/A | N/A | N/A | N/A | 5,207 |
| Operating Expenses | 20,555 | 21,129 | 17,971 | 12,850 | 9,563 |
| Operating Income | -20,555 | -21,129 | -17,971 | -12,850 | -4,356 |
| Interest Expense | 0 | 0 | 128 | 208 | 234 |
| Other Income | 1,106 | 2,566 | 568 | -3,947 | -453 |
| Pre-tax Income | -19,449 | -18,563 | -17,531 | -17,005 | -5,043 |
| Net Income Continuous | -19,449 | -18,563 | -17,531 | -17,005 | -5,043 |
| Net Income | $-19,449 | $-18,563 | $-17,531 | $-17,005 | $-5,043 |
| EPS Basic Total Ops | -0.32 | -0.31 | -0.30 | -0.32 | -0.07 |
| EPS Basic Continuous Ops | -0.33 | -0.31 | -0.30 | -0.32 | -0.07 |
| EPS Diluted Total Ops | -0.30 | -0.34 | -0.30 | -0.32 | -0.07 |
| EPS Diluted Continuous Ops | -0.33 | -0.31 | -0.30 | -0.32 | -0.07 |
| EBITDA(a) | $-21,076 | $-21,696 | $-18,457 | $-13,116 | $-4,499 |